Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment
Abstract Lymphoma is the most common hematological cancer in dogs. Canine diffuse large B cell lymphoma shows a relatively good response to treatment with multi-agent cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy; however, the 2-year survival rate is as low as 20%. F...
Guardado en:
Autores principales: | Takuya Mizuno, Yukinari Kato, Mika K. Kaneko, Yusuke Sakai, Toshinori Shiga, Masahiro Kato, Toshihiro Tsukui, Hirofumi Takemoto, Akio Tokimasa, Kenji Baba, Yuki Nemoto, Osamu Sakai, Masaya Igase |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e1433744f59a4ad9a18dbad654843c03 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs
por: Masaya Igase, et al.
Publicado: (2020) -
Characterization of Egyptian Isolates of Canine Distemper and Canine Parvoviruses
por: M.H. Khodeir, et al.
Publicado: (2021) -
A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma
por: Naoya Maekawa, et al.
Publicado: (2017) -
Canine scent detection of canine cancer: a feasibility study
por: Dorman DC, et al.
Publicado: (2017) -
Effects of the canine rattlesnake vaccine in moderate to severe cases of canine crotalid envenomation
por: Leonard MJ, et al.
Publicado: (2014)